← Back to catalogue

BinaxNOW COVID-19/Flu A&B Controls

FDA UDI

Class II (US FDA UDI)

by Alere Scarborough, Inc.

Identity

Trade Name
BinaxNOW COVID-19/Flu A&B Controls FDA UDI
Generic Name
Multiple-genus respiratory virus antigen IVD, control FDA UDI
Device Name
Intended for detection of proteins from Influenza A, Influenza B and SARS-CoV-2, not for any other viruses or pathogens FDA UDI
Model / Reference
20002055 FDA UDI
Description
Intended for detection of proteins from Influenza A, Influenza B and SARS-CoV-2, not for any other viruses or pathogens FDA UDI

Identifiers

Primary DI / UDI-DI
00811877012108 FDA UDI
FDA Product Code
SCA FDA UDI
GMDN Term
Multiple-genus respiratory virus antigen IVD, control FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.3987 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Multiple-genus respiratory virus antigen IVD, control

BinaxNOW COVID-19/Flu A&B Controls by Alere Scarborough, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Multiple-genus respiratory virus antigen IVD, control.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI a124c3e4-b238-4391-af5e-715ed4d36f99 33 fields · synced Jun 8, 2026